Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01033383 · ClinicalTrials.gov registry record · Phase 1
Dosing Study of Cranberry Capsules for the Prevention of Bacteriuria in Nursing Home Residents
A Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 1
- Development phase
- 80
- Enrollment target
NCT01033383 is a Phase 1 study that has completed, run by Yale University. The registered enrollment target is 80 participants.
The verdict
NCT01033383, a Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 80 participants
- Enrollment target
Study Summary
This study will investigate whether there is a particular dose of cranberry capsules that is effective in preventing the occurrence of urinary tract infections in females at least 65 years of age or older who live in a nursing home and who have a history of urinary tract infections. The Yale research team will be enrolling 80 subjects in total over several nursing home locations within Connecticut.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Cranberry Capsule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2009-12 |
| Est. Completion | 2010-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01033383
The ClinicalTrials.gov registry entry for NCT01033383 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01033383 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01033383 about?
NCT01033383 is a clinical study titled "Dosing Study of Cranberry Capsules for the Prevention of Bacteriuria in Nursing Home Residents". This study will investigate whether there is a particular dose of cranberry capsules that is effective in preventing the occurrence of urinary tract infections in females at least 65 years of age or older who live in a nursing home and who have a history of urinary tract infections. The Yale researc...
What is the current status of trial NCT01033383?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 80 participants. The study started on 2009-12. Estimated completion is 2010-12.
What interventions are being tested in trial NCT01033383?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Cranberry Capsule (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01033383?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.